Promoter Methylation of PRKCB, ADAMTS12, and NAALAD2 Is Specific to Prostate Cancer and Predicts Biochemical Disease Recurrence

The molecular diversity of prostate cancer (PCa) has been demonstrated by recent genome-wide studies, proposing a significant number of different molecular markers. However, only a few of them have been transferred into clinical practice so far. The present study aimed to identify and validate novel...

Descripción completa

Detalles Bibliográficos
Autores principales: Daniunaite, Kristina, Bakavicius, Arnas, Zukauskaite, Kristina, Rauluseviciute, Ieva, Lazutka, Juozas Rimantas, Ulys, Albertas, Jankevicius, Feliksas, Jarmalaite, Sonata
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201120/
https://www.ncbi.nlm.nih.gov/pubmed/34198725
http://dx.doi.org/10.3390/ijms22116091

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8201120/
https://www.ncbi.nlm.nih.gov/pubmed/34198725
http://dx.doi.org/10.3390/ijms22116091

Ejemplares similares